Publications

Detailed Information

The Frequency and Clinical Significance of Intra-Uterine Infection and Inflammation in Patients with Placenta Previa and Preterm Labor and Intact Membranes

DC Field Value Language
dc.contributor.authorPark, C. -W.-
dc.contributor.authorMoon, K. C.-
dc.contributor.authorPark, J. S.-
dc.contributor.authorJun, J. K.-
dc.contributor.authorYoon, B. H.-
dc.date.accessioned2012-05-31T00:32:59Z-
dc.date.available2012-05-31T00:32:59Z-
dc.date.issued2009-07-
dc.identifier.citationPLACENTA; Vol.30 7; 613-618ko_KR
dc.identifier.issn0143-4004-
dc.identifier.urihttps://hdl.handle.net/10371/76635-
dc.description.abstractObjective: Histologic placental and/or intra-amniotic inflammation is frequently documented during ascending intra-uterine infections in patients with preterm labor and intact membranes. Placenta previa can be a clinical situation that shows the successive schema of histologic placental and intra-amniotic inflammation during the process of ascending intra-uterine infections. However, a paucity of information exists about the frequency and clinical significance of intra-uterine infections and inflammation in patients with placenta previa and preterm labor and intact membranes. The purpose of this study was to examine this issue. Study design: Amniocentesis was performed on 42 patients with placenta previa and preterm labor and intact membranes (gestational age < 37 weeks). Amniotic fluid (AF) was cultured for aerobic and anaerobic bacteria and genital mycoplasmas, and AF white blood cell (WBC) count and matrix metalloproteinase-8 (MMP-8) concentrations were determined. The diagnosis of intra-amniotic inflammation was made in patients with an elevated AF MMP-8 (>= 23 ng/ml). Non-parametric statistics were used for analysis. Results: 1) Intra-amniotic inflammation was present in 16.7% (7/42), proven AF infection in 4.9% (2/41), and histologic chorioamnionitis in 19.0% (8/42) of patients with placenta previa and preterm labor; 2) Patients with intra-amniotic inflammation had significantly higher rates of a positive AF culture, histologic chorioamnionitis, funisitis, and a shorter interval-to-delivery than those without intra-amniotic inflammation (p < 0.05 for each); 3) Among patients with histologic chorioamnionitis, inflammation of the choriodecidua, which was exposed to the cervical canal, existed in all cases (8/8), but inflammation of the chorionic plate existed in 63% of patients (5/8); 4) Patients with inflammation of the chorionic plate had significantly higher median AF MMP-8 concentrations and WBC counts, and higher rates of intra-amniotic inflammation than those in whom inflammation was restricted to choriodecidua (p < 0.05 for each). Conclusions: Placental inflammation was present in 19.0% and intra-amniotic inflammation was present in 16.7% of patients with placenta previa and preterm labor and intact membranes. The intra-amniotic inflammatory response was stronger when inflammation was present in the chorionic plate and choriodecidua, than when it was restricted to the choriodecidua only, which was exposed to the cervical canal in placenta previa. (C) 2009 Elsevier Ltd. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherElsevierko_KR
dc.subjectPlacenta previako_KR
dc.subjectPreterm laborko_KR
dc.subjectHistologic chorioamnionitisko_KR
dc.subjectIntra-amniotic inflammationko_KR
dc.titleThe Frequency and Clinical Significance of Intra-Uterine Infection and Inflammation in Patients with Placenta Previa and Preterm Labor and Intact Membranesko_KR
dc.typeArticleko_KR
dc.identifier.doi10.1016/j.placenta.2009.04.005-
dc.citation.journaltitlePLACENTA-
dc.description.citedreferencePark CW, 2009, PLACENTA, V30, P56, DOI 10.1016/j.placenta.2008.09.017-
dc.description.citedreferenceSEONG HS, 2008, AM J OBSTET GYNECOL, V199, pE1-
dc.description.citedreferenceSEONG HS, 2008, AM J OBSTET GYNECOL, V375, pE1-
dc.description.citedreferenceOyelese Y, 2006, OBSTET GYNECOL, V107, P927-
dc.description.citedreferenceShim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085-
dc.description.citedreferenceYoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130-
dc.description.citedreferenceMaymon E, 2001, AM J OBSTET GYNECOL, V185, P1143, DOI 10.1067/mob.2001.118166-
dc.description.citedreferenceYoon BH, 2001, AM J OBSTET GYNECOL, V185, P1162-
dc.description.citedreferencePark JS, 2001, AM J OBSTET GYNECOL, V185, P1156-
dc.description.citedreferenceMaymon E, 2001, AM J OBSTET GYNECOL, V185, P1149-
dc.description.citedreferenceLocksmith GJ, 2001, AM J OBSTET GYNECOL, V184, P159-
dc.description.citedreferenceYoon BH, 2000, AM J OBSTET GYNECOL, V182, P675-
dc.description.citedreferenceYoon BH, 1998, OBSTET GYNECOL, V92, P77-
dc.description.citedreferenceSignore CC, 1998, AM J OBSTET GYNECOL, V178, P336-
dc.description.citedreferenceYoon BH, 1996, OBSTET GYNECOL, V88, P1034-
dc.description.citedreferenceYoon BH, 1996, OBSTET GYNECOL, V87, P231-
dc.description.citedreferenceYOON BH, 1995, AM J OBSTET GYNECOL, V172, P960-
dc.description.citedreferenceWATTS DH, 1993, OBSTET GYNECOL, V82, P509-
dc.description.citedreferenceROMERO R, 1992, AM J OBSTET GYNECOL, V167, P1086-
dc.description.citedreferenceWILLIAMS MA, 1991, OBSTET GYNECOL, V78, P14-
dc.description.citedreferenceROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817-
dc.description.citedreferenceSKOLL MA, 1989, AM J OBSTET GYNECOL, V161, P813-
dc.description.citedreferenceROMERO R, 1988, CLIN OBSTET GYNECOL, V31, P553-
dc.description.citedreferenceLEIGH J, 1986, OBSTET GYNECOL, V67, P500-
dc.description.citedreferenceGRAVETT MG, 1986, OBSTET GYNECOL, V67, P229-
dc.description.citedreferenceMCMENAMIN JB, 1984, ANN NEUROL, V15, P285-
dc.description.citedreferenceBANCALARI E, 1979, J PEDIATR, V95, P819-
dc.description.tc7-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share